SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-11
👔
BIOGEN INC.
@BIIB_InsiderForm 4 Filing: Rowinsky Eric K Acquires (Grant) shares of $BIIB
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
BIOGEN INC.
Ticker: $BIIB
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-09
Shares: 1,505
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Rowinsky Eric K, holds the title of Director at BIOGEN INC..
On 2026-06-09, the insider transacted 1,505 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Rowinsky Eric K (Director) was granted $0 of $BIIB
Post-Transaction Position: 25,844 shares
SEC Accession No: 0000875045-26-000063 (CIK: 1318886)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.